Prabodh Agrawal of IIFL Institutional Equities has sharply reduced this year's Nifty earnings estimate to 8 percent from 16-17 percent at the beginning of the year
On the macro front, Prabodh Agrawal, president and head of research at IIFL Institutional Equities, continues to remain positive. He says even if GST implementation gets delayed by three months, it should not be an issue.
Prabodh Agrawal of IIFL Institutional Equities says earnings will be the main driver of the market in the coming quarters. He is not betting on the market correcting 10%. He says cement, IT and auto sectors can see earnings upgrade over next 1-2 years.
Prabodh Agrawal, president and head of research at IIFL Institutional Equities expects announcements pertaining to increase in spending in physical and social infrastructure in the Budget. He adds that this increase will partly be funded through increase in taxes â€“ primarily indirect taxes.
Sandeep Muthangi, VP Research at IIFL Institutional Equities prefers prefer HCL Technologies and Wipro.
The debate on IT giant Infosys‘ results has multiple angles now, as it is likely to be a big trigger for all IT stocks. The company is going to announce its fourth quarter numbers on Friday. Sandeep Muthangi, Vice President - Research, IIFL Institutional Equities expects the company to give guidance of 12 percent odd growth for the next year.
Sandeep Muthangi, Vice President - Research, IIFL Institutional Equities advises to prefer Wipro and HCL Tech over Infosys.
Expect 20% return in Sun Pharma, says Bino Pathiparampil, IIFL Institutional Equities.
Cash flow improvement may lead to Glenmark re-rating, says Bino Pathiparampil, IIFL Institutional Equities.
According to pharma analyst Bino Pathiparampil of IIFL Institutional Equities Sun Pharma could make USD 100 million from Doxil.
In an interview with CNBC-TV18, Sandeep Muthangi of IIFL Institutional Equities spoke about his reading and outlook for Infosys, which will announce its third quarter numbers on Friday.
GV Giri, analyst at IIFL Institutional Equities believes the tariff hikes would not influence their sales volumes too much but, may result in some revenue growth given the low price elasticity.
Due to the weak global demand environment and adverse cross-currency movements, Sandeep Muthangi of IIFL Institutional Equities says IT major Infosys may cut its dollar revenue guidance for the year.
India's largest lender State Bank of India will declared its fourth quarter results today. In an interview to CNBC-TV18, Sampath Kumar of IIFL Institutional Equities says, he sees slippages anywhere between Rs 6,000-8,000 crore on gross basis.
In the debate between TCS and Infosys, Sandeep Muthangi of IIFL tells CNBC-TV18 that he picks Wipro.
2012 is likely to be yet another tumultuous and abrasive one for Indian equities, says H Nemkumar of IIFL Institutional Equities. The downdraft in business cycle led by deterioration in a number of macro economic variables may worsen.
Public sector banks have been a put-off this earnings season, with Union Bank and Oriental Bank of Commerce disappointing the most, says Sampath Kumar, senior research analyst at IIFL Institutional Equities.
Bank of America Merrill Lynch maintains a 'buy' on Dr Reddy's, but has cut the price target to Rs 1,860. EPS estimates have been trimmed due to transition to IFRS financials, the Mexico facility import alert, and moderation of domestic formulations growth to 17% from 20%.
With the possibility of further growth deceleration, the investment cycle showing no signs of pick-up, we expect more downgrades to the consensus earnings estimates post Q1.
FMCG firms are set to gain from decline in palm oil and other commodity prices, but most of them ruled out cutting prices of their products.